DSM-Firmenich AG (XTER:ZX6) Piotroski F-Score

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTER:ZX6 DSM-Firmenich AG XTER:ZX6
41 GF Score
Price €90.20
GF Value €83.72
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is DSM-Firmenich AG Piotroski F-Score?

DSM-Firmenich AG does not have enough data to calculate Piotroski F-Score.

DSM-Firmenich AG  (XTER:ZX6) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


DSM-Firmenich AG Piotroski F-Score Related Terms


DSM-Firmenich AG Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for DSM-Firmenich AG's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DSM-Firmenich AG Piotroski F-Score Chart

DSM-Firmenich AG Annual Data
Trend Dec21 Dec23 Dec24 Dec25
Piotroski F-Score
N/A N/A N/A 5.00

DSM-Firmenich AG Quarterly Data
Jun22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Piotroski F-Score Get a 7-Day Free Trial 0.00 N/A 0.00 5.00 0.00

XTER:ZX6 vs : Piotroski F-Score Comparison

For the Specialty Chemicals subindustry, DSM-Firmenich AG's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DSM-Firmenich AG Piotroski F-Score vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, DSM-Firmenich AG's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where DSM-Firmenich AG's Piotroski F-Score falls into.


XTER:ZX6
41GF Score
DSM-Firmenich AG XTER:ZX6
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is DSM-Firmenich AG (XTER:ZX6) Overvalued in 2026?

Based on GuruFocus' analysis, DSM-Firmenich AG stock appears to be overvalued. The current stock price of €90.20 is trading 7.7% above its estimated GF Value™ of €83.72. GuruFocus considers DSM-Firmenich AG to be Fairly Valued.

Key valuation signals for XTER:ZX6:

  • Piotroski F-Score:
  • GF Value™: €83.72 vs. price of €90.20 (7.7% above fair value)
  • GF Score™: 41/100 with 8 warning signs

No single metric tells the full story. See the XTER:ZX6 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


DSM-Firmenich AG Business Description

Comparable Companies
Address Wurmisweg 576, Kaiseraugst, CHE, 4303
DSM-Firmenich is a global science-based company formed in 2023 through the merger of DSM, a Dutch nutrition, health, and sustainable living player, and Switzerland-based Firmenich, the third-largest player in the flavor and fragrance market. The company serves a wide range of end-consumer markets providing nutrition solutions ranging from medical and early-life nutrition, fragrances for personal-, home-, and laundry-care brands, prestige perfumes, and other ingredients for food and beverage, home, and personal care. DSM-Firmenich has nearly 30,000 employees, with more than 2,000 scientists and engineers spread across 15 research and development facilities.
41GF Score

Get the complete analysis for XTER:ZX6

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€90.20
Price
€83.72
GF Value